Skip to main content

Peer Review reports

From: Promoter methylation of transient receptor potential melastatin-related 7 (TRPM7) predicts a better prognosis in patients with Luminal A breast cancers

Original Submission
29 Apr 2022 Submitted Original manuscript
6 Jun 2022 Reviewed Reviewer Report
14 Jun 2022 Reviewed Reviewer Report
7 Jul 2022 Author responded Author comments - Yiping Qu
Resubmission - Version 2
7 Jul 2022 Submitted Manuscript version 2
10 Jul 2022 Author responded Author comments - Yiping Qu
Resubmission - Version 3
10 Jul 2022 Submitted Manuscript version 3
29 Jul 2022 Reviewed Reviewer Report
8 Aug 2022 Reviewed Reviewer Report
15 Aug 2022 Author responded Author comments - Yiping Qu
Resubmission - Version 4
15 Aug 2022 Submitted Manuscript version 4
Publishing
23 Aug 2022 Editorially accepted
5 Sep 2022 Article published 10.1186/s12885-022-10038-z

You can find further information about peer review here.

Back to article page